ORANGEBIOMED
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99212976
- Mark type
- Stylized text
- Filed
- 02 Jun 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- April Besl
Goods and services
- Class 010 — Medical apparatus: HbA1c monitoring cartridge unit for home use including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of medical apparatus for monitoring blood; medical test kits for HbA1c diabetes monitoring for home use; diabetic monitoring apparatus in the nature of medical test kits for diabetes monitoring for home use; HbA1c testing apparatus for diabetes monitoring in the nature of medical test kits for diabetes monitoring for home use; diabetes monitoring apparatus for analyzing HbA1c in the nature of medical test kits for diabetes monitoring for home use; HbA1c measuring apparatus for monitoring diabetes in the nature of medical test kits for diabetes monitoring for home use; biopsy needles; continuous blood glucose monitor in the nature of medical apparatus for monitoring blood glucose levels; medical apparatus and instruments other than for dental purposes for measuring blood glucose levels; medical HbA1c monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of devices for monitoring blood sugar control; medical blood monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c in the nature of devices for monitoring blood sugar control; medical apparatus for blood analysis; blood analysis apparatus for diagnosis of diabetes; blood glucose monitoring medical apparatus; medical devices for measuring blood sugar
- Class 035 — Advertising and business services: Retail store services featuring diabetes monitoring apparatus for analyzing HbA1c for home use; Retail store services featuring medical test kits for HbA1c diabetes monitoring for home use; Retail store services featuring diabetes monitoring apparatus; Retail store services featuring diabetes monitoring apparatus for analyzing HbA1c; Retail store services featuring biopsy needles; Retail store services featuring continuous blood glucose monitor; Retail store services featuring medical apparatus and instruments other than for dental purposes; Retail store services featuring medical HbA1c monitoring cartridge unit including a microfluidic channel and microelectrodes for measuring blood HbA1c; Retail store services featuring medical apparatus for blood analysis; Retail store services featuring blood analysis apparatus for diagnosis of diabetes; Retail store services featuring blood glucose monitoring apparatus
- Class 042 — Scientific and technological services: Development of diabetes measuring apparatus in the nature of product development; development of biopsy needles in the nature of product development; development of diagnostic preparation materials for medical and veterinary purposes in the nature of product development; development of medical apparatus and instruments other than for dental purposes in the nature of product development; development of medical diagnostic reagents in the nature of product development; development of medical apparatus for blood analysis in the nature of product development; development of test strips for measuring blood glucose levels in the nature of product development; development of medical diagnostic test strips for analyzing blood in the nature of product development
Owner
- Orange Biomed Co., Ltd, Seoul, KR
- Orange Biomed Co., Ltd, Seoul, KR
Prosecution history
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 02 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 02 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 16 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION WRITTEN
- 21 Oct 2025 — ASSIGNED TO EXAMINER